Abemaciclib and Treosulfan: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abemaciclib
Treosulfan
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Your body uses an enzyme called CYP3A4 to break down abemaciclib (Verzenio). Treosulfan can slow that enzyme down. When it does, abemaciclib can build up in your blood higher than expected, which may lead to stronger side effects like diarrhea, nausea, tiredness, or low blood cell counts.
I want to be clear that this concern is based on how treosulfan is understood to work, not on strong studies, so it is more of a caution than a proven problem. Please don't change anything on your own. Your cancer care team knows how to handle this by watching you closely and adjusting your dose if needed.
Mechanism: Treosulfan is a predicted CYP3A4 inhibitor; abemaciclib is a CYP3A4 substrate. Inhibition of CYP3A4-mediated metabolism may increase abemaciclib exposure (AUC/Cmax), raising the risk of dose-related toxicities (diarrhea, neutropenia, hepatotoxicity, VTE, ILD).
- Direction: Increased abemaciclib effect/toxicity (neither drug is a prodrug requiring activation).
- Severity: Major.
- Onset: Unspecified.
- Evidence: Theoretical, mechanistic prediction.
Management: Monitor closely for abemaciclib adverse reactions (CBC, LFTs, GI symptoms). Reduce abemaciclib dosage as needed; individualize per response and tolerability.
What happens
Increased CYP3A4 substrate exposure and an increased risk of CYP3A4 substrate-related adverse and serious life-threatening toxicities
Interaction Deep Dive
When treosulfan, a CYP3A4 inhibitor, is given together with CYP3A4 substrates for which only small changes in concentration are expected, the exposure to those CYP3A4 substrates is predicted to rise, based on a mechanistic understanding of how treosulfan is metabolized. This elevated exposure may heighten the likelihood of adverse reactions from the substrates. For certain CYP3A4 substrates that are narrow therapeutic index (NTI) drugs, monitoring for adverse reactions is warranted because such reactions can result in serious or life-threatening toxicities, and the dosage should be lowered when necessary1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism by treosulfan
How to manage this interaction
The good news is this is manageable. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.
- Your team may monitor you more closely for abemaciclib side effects, including blood counts, liver tests, and symptoms like diarrhea or unusual fatigue.
- Your abemaciclib dose may need to be adjusted and individualized by your care team if side effects show up.
- Report new or worsening diarrhea, fever, shortness of breath, yellowing of the skin, or severe tiredness right away.
Ask your pharmacist or oncologist how they plan to watch for these effects while you are on both drugs.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abemaciclib and Treosulfan together?
Treosulfan may slow the breakdown of abemaciclib, letting it build up and raising the chance of side effects, so your care team will watch you closely and may lower your abemaciclib dose if needed. This concern is theoretical, so don't change anything on your own, just stay in touch with your team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abemaciclib and Treosulfan interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Abemaciclib and Treosulfan interaction managed?
The good news is this is manageable. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Your team may monitor you more closely for abemaciclib side effects, including blood counts, liver tests, and symptoms like diarrhea or unusual fatigue. Your abemaciclib dose may need to be adjusted and individualized by your care team if side effects show up. Report new… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Abemaciclib or Treosulfan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: GRAFAPEX(TM) intravenous injection, treosulfan intravenous injection. Medac GmbH (per FDA), Wedel, Germany, 2025. DailyMed
Keep reading about Abemaciclib
Keep reading about Treosulfan
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist